ROCO
6518
Market cap33mUSD
Jul 09, Last price
32.00TWD
1D
-1.54%
1Q
21.67%
Jan 2017
60.97%
IPO
-15.30%
Name
Concord Medical Co Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Concord Medical Co., Ltd. delivers extensive support services for hospital administration across Taiwan, Myanmar, and China. The company's portfolio of services includes critical medical management assistance, covering professional training for healthcare staff, the provision of nursing personnel, and general operational guidance. Additionally, Concord Medical offers comprehensive procurement solutions, sourcing a broad spectrum of items such as medical devices, pharmaceuticals, general medical supplies and consumables, as well as specialized inspection equipment and laboratory reagents. Expanding its ventures, the firm also develops and markets its own proprietary brands, which feature aesthetic healthcare products, nutritional supplements, and prepared traditional Chinese medicines. Furthermore, Concord Medical is actively involved in the strategic planning and sales of medical equipment, alongside offering medical apparatus leasing services. Concord Medical Co., Ltd. was established in 2009 and is headquartered in New Taipei City, Taiwan.
Valuation
Title TWD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | |||||||
Revenues | |||||||
Cost of revenue | |||||||
Unusual Expense (Income) | |||||||
NOPBT | |||||||
NOPBT Margin | |||||||
Operating Taxes | |||||||
Tax Rate | |||||||
NOPAT | |||||||
Net income | |||||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | |||||||
BB yield | |||||||
| Debt | |||||||
Debt current | |||||||
Long-term debt | |||||||
Deferred revenue | |||||||
Other long-term liabilities | |||||||
Net debt | |||||||
| Cash flow | |||||||
Cash from operating activities | |||||||
CAPEX | |||||||
Cash from investing activities | |||||||
Cash from financing activities | |||||||
FCF | |||||||
| Balance | |||||||
Cash | |||||||
Long term investments | |||||||
Excess cash | |||||||
Stockholders' equity | |||||||
Invested Capital | |||||||
ROIC | |||||||
ROCE | |||||||
| EV | |||||||
Common stock shares outstanding | |||||||
Price | |||||||
Market cap | |||||||
EV | |||||||
EBITDA | |||||||
EV/EBITDA | |||||||
Interest | |||||||
Interest/NOPBT | |||||||